Demeter Bio Overview
- Year Founded
-
2025
- Status
-
Private
- Employees
-
4
- Latest Deal Type
-
Early Stage VC
- Investors
-
8
Demeter Bio General Information
Description
Developer of advanced performance materials designed to replace conventional, resource-intensive components across sectors. The company's platform integrates novel material formulations and scalable processing technologies to deliver enhanced mechanical, thermal, and functional properties, enabling manufacturers to improve product performance while reducing environmental impact.
Contact Information
Website
www.demeter-bio.comCorporate Office
- 192 Drummond Street
- London NW1 3HP
- England, United Kingdom
Corporate Office
- 192 Drummond Street
- London NW1 3HP
- England, United Kingdom
Demeter Bio Timeline
Demeter Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Early Stage VC | 30-Jun-2026 | Completed | Generating Revenue | |||
| 5. Early Stage VC | 01-Oct-2025 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | 01-Jan-2025 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | 01-Jan-2025 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 1. Accelerator/Incubator | Completed | Generating Revenue |
Demeter Bio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | 117,500 | $0.000013 | $1.63 | $1.63 | 1x | $1.63 | 6.43% | |
| Ordinary | 335,713 | $0.000013 | $4.48 | $4.48 | 1x | $4.48 | 18.37% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Demeter Bio Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Demeter Bio Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Demeter Bio Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| British Design Fund | Venture Capital | Minority | ||
| WilkinsonFuture | Corporate Venture Capital | Minority | ||
| One Planet Capital | Venture Capital | Minority | ||
| SyndicateRoom | Venture Capital | Minority | ||
| biotope by VIB | Accelerator/Incubator |
Demeter Bio FAQs
-
When was Demeter Bio founded?
Demeter Bio was founded in 2025.
-
Where is Demeter Bio headquartered?
Demeter Bio is headquartered in London, United Kingdom.
-
What is the size of Demeter Bio?
Demeter Bio has 4 total employees.
-
What industry is Demeter Bio in?
Demeter Bio’s primary industry is Multi-line Chemicals.
-
Is Demeter Bio a private or public company?
Demeter Bio is a Private company.
-
What is Demeter Bio’s current revenue?
The current revenue for Demeter Bio is .
-
How much funding has Demeter Bio raised over time?
Demeter Bio has raised $2.14M.
-
Who are Demeter Bio’s investors?
British Design Fund, WilkinsonFuture, One Planet Capital, SyndicateRoom, and biotope by VIB are 5 of 8 investors who have invested in Demeter Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
